2019
DOI: 10.1007/s10519-019-09980-9
|View full text |Cite
|
Sign up to set email alerts
|

Interaction Between Odor Identification Deficit and APOE4 Predicts 6-Year Cognitive Decline in Elderly Individuals

Abstract: Olfactory identification impairment might indicate future cognitive decline in elderly individuals. An unresolved question is to what extent this effect is dependent on the ApoE-ε4, a genotype associated with risk of Alzheimer's Disease (AD). Given the current concern about reproducibility in empirical research, we assessed this issue in a large sample (n = 1637) of older adults (60 -96 years) from the population-based longitudinal Swedish National Study on Aging and Care in Kungsholmen (SNAC-K). A hierarchica… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 21 publications
(16 citation statements)
references
References 76 publications
0
16
0
Order By: Relevance
“…As expected, the percentage of carriers of one or two APOE4 alleles was significantly higher in the aMCI/mAD group than among controls. Harboring APOE4 alleles affects olfaction even in healthy older adults ( 9 ), and the group difference in brain activity could be enhanced by this imbalance. Nevertheless, an APOE4 imbalance will be present in studies of aMCI/AD compared to health elderly due to the importance of APOE4 for AD risk ( 55 ).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…As expected, the percentage of carriers of one or two APOE4 alleles was significantly higher in the aMCI/mAD group than among controls. Harboring APOE4 alleles affects olfaction even in healthy older adults ( 9 ), and the group difference in brain activity could be enhanced by this imbalance. Nevertheless, an APOE4 imbalance will be present in studies of aMCI/AD compared to health elderly due to the importance of APOE4 for AD risk ( 55 ).…”
Section: Discussionmentioning
confidence: 99%
“…As healthy older adults also experience a decline in odor detection and discrimination, but not a similar reduction in OI, OI is considered to separate people with aMCI or AD from older people with intact cognition ( 5 , 7 ). Importantly, OI ability is shown to predict both a later diagnosis of MCI in healthy older adults and conversion from MCI to dementia ( 8 , 9 ). Hence, OI testing can be used as an inexpensive and non-invasive supplement in the clinical evaluation of suspected AD ( 1 , 10 ).…”
Section: Introductionmentioning
confidence: 99%
“…In relation to this, however, there have been some interesting findings. Several studies have noted that olfactory impairment has greater salience – is a stronger predictor of decline – among individuals who carry the APOE 4 allele (Graves et al, 1999 ; Olofsson et al, 2020 ). One way to interpret this finding is that the presence of a known strong risk factor for AD (i.e., APOE ε4) increases the likelihood that olfactory impairment, when present, has a neurodegenerative (central not peripheral) basis.…”
Section: Discussionmentioning
confidence: 99%
“…Here, we use a large dataset ( Larsson et al 2016 ) with 2,476 participants in the age range of 60–100 years to investigate how odor identification is related to perceptual odor features. In previous research, this dataset has been used to understand risk factors for olfactory dysfunction ( Palmquist et al 2020 ), and the relationship between olfactory and cognitive dysfunction ( Olofsson et al 2020 ), using aggregated odor identification scores. The aim of the present study was to understand odor identification performance using odor item information as a function of perceptual dimensions.…”
Section: Introductionmentioning
confidence: 99%